COA on fileShips from United States

Thymulin

Zinc-dependent thymic nonapeptide pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (formerly serum thymic factor, FTS)

An endogenous nonapeptide hormone produced by thymic epithelial cells, biologically active only when coordinated to zinc. Formerly called serum thymic factor (FTS). Studied in T-cell differentiation, neuroendocrine-immune signalling and inflammatory cell models.

Thymulin is a nonapeptide hormone of thymic epithelial cell origin, sequence pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, with an N-terminal pyroglutamate and a free C-terminal carboxyl. PubChem CID 71300623 records the metal-free peptide as C33H54N12O15, 858.9 g/mol, under CAS 78922-62-0, and its IUPAC name independently confirms the residue order. Unlike the other entries in this group it is not a Khavinson bioregulator and has an entirely separate provenance: it was characterised in France by Bach and Dardenne as facteur thymique serique, and "FTS" in the older literature denotes the zinc-free apopeptide (see PMID 2189748, which describes FTS explicitly as "zinc-free thymulin"). The distinction is chemical, not semantic — thymulin proper is the zinc complex.

Zinc coordination is the defining structural feature. The 2004 Peptides review "Thymulin and the neuroendocrine system" describes it as a thymic hormone exclusively produced by thymic epithelial cells, consisting of a nonapeptide component coupled to the zinc ion, which confers biological activity (PMID 15003367). Study systems in the indexed literature include T-cell differentiation assays, hypothalamic-pituitary-thymic axis work, gonadotropin-releasing activity in pituitary cell preparations across age (PMID 10811143), and endotoxin-stimulated alveolar epithelial cells, where thymulin and zinc were examined against proinflammatory cytokine production, cAMP-dependent signalling and NF-kB nuclear translocation (PMID 19850345).

On the evidence base: thymulin differs from the rest of this group in that it is a mainstream immunology subject with a large multi-national literature going back to the 1970s, including substantial independent replication of its existence, zinc dependence and thymic origin. What it does not have is a therapeutic track record. No thymulin product holds a marketing authorisation in any jurisdiction I could verify, contemporary work remains preclinical, and analytical handling is non-trivial because the zinc-free and zinc-bound forms are distinct species with different activity. Material supplied as "thymulin" is in practice usually the synthetic apopeptide.

Specification

CAS number78922-62-0
Molecular formulaC33H54N12O15
Molecular weight858.9 g/mol (metal-free nonapeptide; the biologically active zinc-bound form is heavier)
SequencepGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn (Glp-AKSQGGSN), free acid, all L-configuration; biological activity requires a coordinated Zn(2+) ion
AppearanceLyophilised white powder
StorageStore at -20°C, protect from light

Batch records & certificates

Every lot we hold of this compound, across all warehouses. The certificate is tied to that lot number — not a generic sample document.

LotWarehousePurityTestedLaboratoryDocuments
THY20-021326All warehouses99.4%19 Feb 2026Analytical Formulations Inc.COA
All products listed on this site are sold strictly as laboratory reagents for in-vitro research and analytical use. They are not drugs, foods, cosmetics or medical devices, and are not intended to diagnose, treat, cure or prevent any disease. They are not for human or veterinary consumption or administration. Purchasers must be qualified researchers or institutions and are solely responsible for compliance with all applicable laws.